AXM Pharma, Inc.
AXMP
$0.0001
$0.000.00%
OTC PK
| 06/30/2018 | 03/31/2018 | ||||
|---|---|---|---|---|---|
| Revenue | 0.00% | 27.62% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 0.00% | 27.62% | |||
| Cost of Revenue | 0.00% | 41.69% | |||
| Gross Profit | 0.00% | -18.18% | |||
| SG&A Expenses | 0.00% | -46.43% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | 0.00% | 272.57% | |||
| Total Operating Expenses | 0.00% | 32.50% | |||
| Operating Income | 0.00% | -4.67% | |||
| Income Before Tax | 0.00% | -33.98% | |||
| Income Tax Expenses | 0.00% | -68.22% | |||
| Earnings from Continuing Operations | 0.00% | -13.30% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 0.00% | -13.30% | |||
| EBIT | 0.00% | -4.67% | |||
| EBITDA | 0.00% | -5.34% | |||
| EPS Basic | 0.00% | 0.00% | |||
| Normalized Basic EPS | 0.00% | -25.00% | |||
| EPS Diluted | 0.00% | 0.00% | |||
| Normalized Diluted EPS | 0.00% | -25.00% | |||
| Average Basic Shares Outstanding | 0.00% | 0.00% | |||
| Average Diluted Shares Outstanding | 0.00% | 0.00% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||